For advanced-stage CRC, chemotherapy is commonly recommended, and targeted therapies including anti-epidermal growth factor receptor (anti-EGFR) agents are frequently used in combination with chemotherapy (Rawla et al., 2019; Wang et al., 2019). Here, EGFR is linked to colorectal carcinoma.